Twin Tree Management, LP Biomarin Pharmaceutical Inc Transaction History

Twin Tree Management, LP

  • $51.8 Billion
  • Q2 2025

A detailed history of Twin Tree Management, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Twin Tree Management, LP holds 10,703 shares of BMRN stock, worth $593,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,703
Previous 51,280 79.13%
Holding current value
$593,267
Previous $3.62 Million 83.77%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
SELL
$54.08 - $68.32 $2.19 Million - $2.77 Million
-40,577 Reduced 79.13%
10,703 $588,000
Q1 2025

May 15, 2025
BUY
$61.25 - $72.83 $3.14 Million - $3.73 Million
51,280 New
51,280 $3.62 Million
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $2.23 Million - $2.77 Million
29,986 Added 742.96%
34,022 $2.8 Million
Q1 2024

May 09, 2024
SELL
$83.81 - $99.0 $4.66 Million - $5.51 Million
-55,649 Reduced 93.24%
4,036 $352,000
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $985,677 - $1.27 Million
12,932 Added 27.66%
59,685 $5.75 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $3.98 Million - $4.42 Million
46,753 New
46,753 $4.14 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $2.89 Million - $3.88 Million
35,714 Added 114.07%
67,022 $6.94 Million
Q3 2022

Nov 10, 2022
BUY
$82.16 - $96.94 $948,126 - $1.12 Million
11,540 Added 58.38%
31,308 $2.65 Million
Q2 2022

Aug 11, 2022
SELL
$71.48 - $86.85 $437,028 - $531,000
-6,114 Reduced 23.62%
19,768 $1.64 Million
Q1 2022

May 11, 2022
SELL
$74.28 - $92.69 $696,226 - $868,783
-9,373 Reduced 26.59%
25,882 $2 Million
Q4 2021

Feb 10, 2022
BUY
$71.72 - $91.47 $1.69 Million - $2.15 Million
23,554 Added 201.3%
35,255 $3.12 Million
Q2 2021

Aug 12, 2021
BUY
$75.51 - $84.79 $415,833 - $466,938
5,507 Added 88.91%
11,701 $976,000
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $2.67 Million - $3.25 Million
-35,784 Reduced 85.24%
6,194 $468,000
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $1.73 Million - $2.15 Million
23,814 Added 131.11%
41,978 $3.68 Million
Q3 2020

Nov 13, 2020
SELL
$71.87 - $131.03 $2.5 Million - $4.56 Million
-34,830 Reduced 65.72%
18,164 $1.38 Million
Q2 2020

Aug 12, 2020
BUY
$79.55 - $124.22 $4.22 Million - $6.58 Million
52,994 New
52,994 $6.54 Million
Q2 2019

Aug 12, 2019
SELL
$80.35 - $93.9 $32,220 - $37,653
-401 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$84.2 - $98.62 $33,764 - $39,546
401 New
401 $36,000
Q2 2018

Aug 08, 2018
SELL
$76.01 - $99.03 $40,589 - $52,882
-534 Closed
0 $0
Q1 2018

May 09, 2018
BUY
$77.67 - $92.63 $41,475 - $49,464
534 New
534 $43,000

Others Institutions Holding BMRN

# of Institutions
674
Shares Held
185M
Call Options Held
1.31M
Put Options Held
1.1M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email